Lv3
280 积分 2021-08-03 加入
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
16天前
已完结
Prevalence of Hidradenitis Suppurativa
23天前
已完结
中国银屑病诊疗指南（2023版）
24天前
已完结
IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
1个月前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
1个月前
已完结
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
1个月前
已完结
IL-17信号通路调控机制及其在炎症性疾病中的干预策略研究
1个月前
已完结
The CD70–CD27 Axis in Cancer Immunotherapy: Predictive Biomarker and Therapeutic Target
1个月前
已完结
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)
2个月前
已完结
皖公网安备34019202002308
